Skip to main content

Advertisement

Figure 3 | Clinical Proteomics

Figure 3

From: Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery

Figure 3

The common quantitative aim and related strategies for N-glycoproteome. (a) Interpreting alterations in glycoproteomics. Changes in site specific glycosylation level; Changes in protein expression level; Changes in glycosylation occupancy level. Glycosylation site is depicted by a filled red circle. (b) Specific quantitative strategies for different goals. “D” denote disease sample, “C” denote control sample.

Back to article page